Arvinas To Cut Jobs, Out-License Vepdegestrant, And Launch $100 Mln Stock Buyback Plan
Neutral
-0.5
(RTTNews) - Arvinas Inc. (ARVN) and Pfizer Inc. (PFE) announced plans to jointly select a third party for the out-licensing and commercialization of vepdegestrant. As part of its operational streamlining, Arvinas will reduce its workforce by an additional 15%, with the most signi
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
